JP2025523933A5 - - Google Patents
Info
- Publication number
- JP2025523933A5 JP2025523933A5 JP2025502639A JP2025502639A JP2025523933A5 JP 2025523933 A5 JP2025523933 A5 JP 2025523933A5 JP 2025502639 A JP2025502639 A JP 2025502639A JP 2025502639 A JP2025502639 A JP 2025502639A JP 2025523933 A5 JP2025523933 A5 JP 2025523933A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210863441 | 2022-07-20 | ||
| CN202210863441.9 | 2022-07-20 | ||
| PCT/CN2023/108389 WO2024017331A1 (zh) | 2022-07-20 | 2023-07-20 | 一种抗肾上腺髓质素非中和抗体、其制备方法及应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025523933A JP2025523933A (ja) | 2025-07-25 |
| JP2025523933A5 true JP2025523933A5 (https=) | 2025-08-08 |
| JPWO2024017331A5 JPWO2024017331A5 (https=) | 2025-08-08 |
Family
ID=89617212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025502639A Pending JP2025523933A (ja) | 2022-07-20 | 2023-07-20 | 抗アドレノメデュリン非中和抗体、その製造方法及び使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20260035456A1 (https=) |
| EP (1) | EP4559936A1 (https=) |
| JP (1) | JP2025523933A (https=) |
| KR (1) | KR20250040987A (https=) |
| CN (1) | CN119546634A (https=) |
| AU (1) | AU2023310494A1 (https=) |
| IL (1) | IL318511A (https=) |
| TW (2) | TWI870936B (https=) |
| WO (1) | WO2024017331A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025152915A1 (zh) * | 2024-01-16 | 2025-07-24 | 上海济煜医药科技有限公司 | 抗肾上腺髓质素抗体在预防或治疗脑卒中的应用 |
| WO2025248139A1 (en) | 2024-05-31 | 2025-12-04 | 4TEEN4 Pharmaceuticals GmbH | Use of adrenomedullin or fragments thereof in the treatment of a patient in need thereof |
| WO2026046978A1 (en) * | 2024-08-26 | 2026-03-05 | Pam Theragnostics Gmbh | Anti-adm antibodies, anti-adm antibody fragment or anti-adm non-ig scaffold for therapy or prevention of immune effector cell therapy side effects |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2780371T3 (en) * | 2011-11-16 | 2019-02-25 | Adrenomed Ag | ANTI-ADDRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTISTOFFRAGMENT OR ANTI-ADM NON-IG TEMPLATE FOR REGULATING LIQUID BALANCE OF A PATIENT WITH A CHRONIC OR ACUTE DISEASE |
| PL2594588T3 (pl) * | 2011-11-16 | 2014-11-28 | Adrenomed Ag | Przeciwciało przeciwko adrenomedulinie (ADM) lub fragment przeciwciała anty-ADM lub szkielet białkowy niestanowiący Ig anty-ADM do zastosowania w terapii |
| EP3339324A1 (en) * | 2016-12-22 | 2018-06-27 | sphingotec GmbH | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in intervention and therapy of congestion in a patient in need thereof |
| FI3687567T3 (fi) * | 2017-09-25 | 2025-01-08 | Adrenomed Ag | Adrenomedulliinin (adm) vasta-ainetta sitova aine käytettäväksi sairauden oireiden hoidossa tai ehkäisyssä |
-
2023
- 2023-07-20 KR KR1020257005234A patent/KR20250040987A/ko active Pending
- 2023-07-20 TW TW112127223A patent/TWI870936B/zh active
- 2023-07-20 AU AU2023310494A patent/AU2023310494A1/en active Pending
- 2023-07-20 EP EP23842393.3A patent/EP4559936A1/en active Pending
- 2023-07-20 CN CN202380054320.2A patent/CN119546634A/zh active Pending
- 2023-07-20 US US18/996,678 patent/US20260035456A1/en active Pending
- 2023-07-20 TW TW113149014A patent/TW202515911A/zh unknown
- 2023-07-20 JP JP2025502639A patent/JP2025523933A/ja active Pending
- 2023-07-20 WO PCT/CN2023/108389 patent/WO2024017331A1/zh not_active Ceased
- 2023-07-20 IL IL318511A patent/IL318511A/en unknown